Is a 1930s law blocking safe cancer info online? new survey investigates
NCT ID NCT07584824
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses anonymous surveys to ask cancer patients, healthcare professionals, and industry workers whether the UK's 1939 Cancer Act—which bans advertising cancer treatments to the public—still works in today's digital world. The goal is to understand how people use online and social media for cancer information and whether the law should be updated. About 50 participants from England and Wales will share their views.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could point toward modernizing the law to better protect patients while allowing safe access to online cancer information.
- What could go wrong
- This is a small survey study (50 participants) that only gathers opinions, not data on health outcomes. It may not represent all views or lead to any legal change.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults geographically resident in England or Wales, who have recent experience in receiving or providing cancer treatment.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients/Relatives: * UK residents (England and Wales ONLY). * Have been treated for a cancer within the last three years. * Aged 18 or over. * Can complete the survey themselves or have it completed on their behalf by a friend or family member (with the patient's permission). Healthcare Professionals: * UK-based professionals in the healthcare industry. * Working with patients diagnosed with cancer. * Consulting with patients at least once a month or more frequently. * Aged 18 or over. Exclusion Criteria: No explicit exclusion criteria are defined within provided materials, therefore any individual not meeting the inclusion criteria will be excluded.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Royal Cornwall Hospitals Trust
RECRUITINGTruro, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?